Xvivo Perfusion AB (publ) (STO: XVIVO)
Sweden
· Delayed Price · Currency is SEK 489.00
-9.50 (-1.91%)
Oct 4, 2024, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 15.40 billion as of October 4, 2024. Its market cap has increased by 76.53% in one year.
Market Cap
15.40B
Enterprise Value
14.95B
Revenue
698.73M
Ranking
n/a
PE Ratio
124.58
Stock Price
489.00
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 15.40B, an increase of 4,044.08%. That is a compound annual growth rate of 36.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,475.34B |
| Swedish Orphan Biovitrum AB (publ) | 104.27B |
| Getinge AB (publ) | 58.64B |
| Sectra AB (publ) | 54.52B |
| Camurus AB (publ) | 38.78B |
| Vitrolife AB (publ) | 31.76B |
| Medicover AB (publ) | 28.17B |
| Elekta AB (publ) | 27.03B |